What’s the difference between MDA and MDMA (ecstasy)?
MDA is one of the main chemicals made when the body breaks down MDMA.3, 7,18
MDA tends to last longer, feel stronger, and cause more psychedelic effects compared to MDMA.9,15
MDA is also less predictable than MDMA, and its effects can vary widely from person to person.15
Both MDA and MDMA are found in illegal drug products and are often sold as ‘ecstasy’.9,18-22
Ecstasy pills, tablets, capsules, powders, or crystals can contain either MDA, MDMA, or both.9,18-22
Drugs sold as ecstasy can also contain many other psychoactive substances, including amphetamines, caffeine, ketamine, and opioids.23,24
If you plan to take MDA or any other illegal drug, visiting a drug checking service can help you find out what is in it.
Pill testing in Australia is conducted through services like CanTEST in Canberra, and The Victorian Pill Testing Service in Melbourne.25
How is MDA used?
MDA is usually swallowed but can also be snorted, smoked, injected, or inserted rectally (plugged/hooped).6,12,13,23
Effects of MDA
The use of any drug can have risks. It’s important to be careful when taking any type of drug.
MDA can affect everyone differently, based on:
- size, weight and health
- whether the person is used to taking it
- whether other drugs are taken around the same time
- the amount taken
- the strength of the drug (varies from batch to batch)
- the environment (where the drug is taken).
Onset and duration of effects
Different ways of taking a drug, such as snorting, swallowing, or injecting, can impact how quickly a drug’s effects are felt.
The effects of MDA can be felt within 15 to 70 minutes when swallowed.6, 15
Effects can last for 5 to 8 hours.9,15
The ‘peak’, when the effects feel most intense, can last about 2.5 to 4 hours.15,26
Immediate effects
The immediate effects of MDA can include:
- increased empathy, affection, and sociability
- increased heartrate and blood pressure
- euphoria (happiness)
- increased laughter
- increased or decreased energy (depending on your mood and environment)
- increased confidence
- high body temperature
- excessive sweating
- dehydration
- teeth grinding or jaw clenching
- large round pupils
- blurry vision/dizziness
- changes in perception, such as visual and auditory hallucinations
- heightened sense of touch
- feeling that your body is very heavy, or very light
- losing track of time
- difficulty urinating
- appetite suppression
- increased sex drive
- temporary erectile dysfunction.2,3,9,15,27
Impact of mood and environment
Drugs that affect a person’s mental state (psychoactive drugs) can also have varied effects depending on a person’s mood (often called the ‘set’) or the environment they are in (the ‘setting’):
- Set: a person’s state of mind, previous encounters with the drug, and expectations of what’s going to happen. For example, feelings of stress or anxiety before using MDA may result in an unpleasant experience and make those feelings worse.
- Setting: the environment in which someone consumes MDA – whether it’s known and familiar, who they’re with, if they’re indoors or outdoors, the type of music and light. For example, using MDA in a relaxed or familiar environment can lead to, or contribute to, a pleasant experience. But being in a noisy, crowded place may result in a negative experience.28
Being in a good state of mind, with trusted friends and a safe environment before taking MDA reduces the risk of having a bad experience.28
Bad trips
A bad trip usually includes anxiety, paranoia, panic, or other negative emotions. People can also experience unpleasant or intense hallucinations.11,29-31
Taking a large dose of MDA can increase the risk of a bad trip. Other things like age, sex, personality, mental state, and previous experience with the drug, can also affect someone’s experience.9,11,29-31
While a bad trip can be scary, it’s generally not life threatening and the effects will go away as the drug leaves someone’s system.11,29-31
Being with trusted friends, in a good state of mind, and in a safe environment before taking any psychedelic drug reduces the risk of having a ‘bad’ trip.30,32
Overdose
If you take a large amount of MDA or have a strong batch, you could overdose.13
MDA can cause death.33,34
Call triple zero (000) and request an ambulance if you or someone else has any of the following symptoms (emergency services are there to help and can provide instructions over the phone):
- passed out and non-responsive
- spasms or seizures
- heart attack symptoms such as:
- difficulty breathing
- sharp pain/discomfort in chest, arm, shoulder, back, neck, or jaw
- severe agitation, confusion, or panic
- racing heartbeat
- very high body temperature (hyperthermia)
- hot, flushed (red), or sweaty skin
- very large pupils.35-38
Mixing with other drugs
Mixing MDA with other drugs can have unpredictable effects and increase the risk of harm.
Mixing also includes drinking alcohol or using medications at the same time or one after another.
- MDA and some antidepressants (MAOI, SSRIs, SNRIs): increases the risk of a dangerous build-up of the serotonin in the brain (known as serotonin syndrome).39
- MDA and depressants (such as alcohol/opioids): can make it difficult to tell the effect that each drug is having on a person, increasing the risk of overdose. Increases the risk of dehydration, seizures (specific to the opioid tramadol), and excessive water consumption.
- MDA and dissociatives (such as ketamine/nitrous oxide): may increase the risk of delusions, unusual or impulsive behaviour (mania), and psychosis.
- MDA and MXE: may dangerously increase blood pressure and increase the risk of unusual or impulsive behaviour (mania), and psychosis.
- MDA and stimulants (such as amphetamines/cocaine): can dangerously increase blood pressure and strain on the heart. Unusual or impulsive behaviour (mania), paranoia, and hallucinations have also been associated with this combination in people who have been taking amphetamines for a long time.15
More on Polydrug use
Polydrug use is a term for the use of more than one drug or type of drug at the same time or one after another. Polydrug use can involve both illicit drugs and legal substances, such as alcohol and medications.
Reducing harm
There are ways in which you can reduce the risks associated with using MDA.
- Start low, go slow – try a little bit first to see how you feel. Wait at least 2 hours before deciding whether to take more.
- Test your drugs - if there is an available drug checking (pill testing) service near you - to find out what the drugs contain and how strong they are.
- Check medication interactions – MDA may interact with other medications you take such as antidepressants or opioid painkillers, which can increase your risk of serotonin syndrome.
- Take regular breaks to cool down – this reduces the risk of overheating and can lower heart rate.
- Use of MDA is safer on cooler days or during the evening – temperatures above 25℃ increase the risk of overheating.
- Drink around 250ml to 500ml of water per hour - to avoid dehydration and prevent water intoxication (hyponatremia), a potentially fatal condition caused by drinking too much water.
- Let a friend know what you’ve taken – so they can help if you’re unwell.
- Try to sleep or rest within a 24-hour period - to prevent sleep deprivation.
- Avoid operating machinery, driving, or swimming. 9,12,23,40-42
If snorting:
- Crush into a fine powder - as crystals can cause cuts.
- Rinse your nose with water before and after use - to protect your nose from irritation.
- Use your own straw, or a disposable one, and avoid money notes - to reduce the risk of infections or transmission of viruses like HIV or hep C.
- Switch nostrils and take breaks - to avoid nasal damage.23,40-42
If injecting:
- Always use new needles – never share needles or other injecting equipment. Use your own spoon/cup and tourniquet. Use new barrels, filters, sterile water, and swabs. Safely dispose of used equipment.
- Visit a needle and syringe program - for sterile equipment, disposal of used equipment, and expert medical advice.23,40-42
Using MDA during sex
If using any drugs during sex, consent must be given and maintained by everyone involved.
This means:
- checking in regularly
- confirming that everyone is awake, alert, and can communicate clearly
- no-one is so affected by alcohol or other drugs that they are unable to make safe or informed decisions
- anyone can stop or change their mind at any time.43,44
Coming down
The comedown of MDA can be more difficult compared to MDMA.15
In the days after using MDA, you may experience:
- anxiety, irritability, and depressed feelings
- appetite suppression
- difficulty concentrating
- trouble sleeping and exhaustion
- brain zaps (small electric shock feelings in the head that can spread through the body)
- thoughts of self-harm or suicide.15,16,45
Long term effects
The long-term effects of MDA are not as well understood as MDMA.9,16
Regular use of MDA may eventually contribute to:
- reduced immune function (regular colds and flu)
- depression
- needing to use more to get the same effect
- memory and concentration problems
- liver problems.16,45
MDA and mental health
MDA changes the levels of certain chemicals in the brain, which affect mood and feelings.2-6
Some evidence suggests it may also influence mental health conditions such as depression and anxiety.15
The 2025 National Ecstasy and Related Drugs Reporting System (EDRS) surveyed people who regularly use ecstasy or other stimulants.13
Over half (57%) reported experiencing a mental health problem in the past six months. Among these, depression and anxiety were the most common.13
This evidence doesn’t mean that using MDA will always cause a mental health problem.13
It’s difficult to say which comes first – mental illness or alcohol and other drug use.46,47
But we do know they influence each other.46,47
For example, someone experiencing mental health problems may take MDA to cope with those feelings. But over time, regular MDA use could contribute to making those symptoms worse.46,47
MDA is also being looked at as an alternative to MDMA in MDMA-assisted therapy.2,4
Tolerance
People who regularly take MDA may develop a tolerance to it, which means they need to take larger amounts to get the same effect.15
Tolerance to the stimulant-like effects of MDA will develop over weeks of use.15
Tolerance to the psychedelic effects of MDA can develop rapidly. Using MDA for several days in a row can make its psychedelic effects much weaker.15
Tolerance to one psychedelic also affects others. For example, using MDA will reduce the effects of LSD or psilocybin mushrooms (magic mushrooms). This is known as cross-tolerance. Tolerance will return to normal after a few days of not using drugs with psychedelic effects.48,49
Dependence
People who regularly use MDA can become psychologically dependent. They may feel they need to use MDA to go about usual activities like socialising.15,50
Withdrawal
Withdrawal refers to the symptoms that can occur when someone who is dependent on MDA or has used it regularly over time, stops or reduces their use.15,51
Withdrawal can include physical symptoms (such as headaches, or nausea) and psychological symptoms (such as anxiety or depressed mood).51
Symptoms - including how strong they are and how long they last - will vary depending on the type of drug and a person’s history of use.51
The withdrawal effects of long-term MDA use are not as well understood.
However, if you experience symptoms after stopping or reducing your use, or have concerns, contact your doctor or the help and support services listed below for advice and support.
Getting help
If your use of MDA is affecting your health, family, relationships, work, school, financial or other life situations, or you’re concerned about someone you care about, there is help and support.
- Call the National Alcohol and Other Drug Hotline on 1800 250 015 for free and confidential advice, information and counselling about alcohol and other drugs.
- Use the ADF’s Path2Help portal to get matched with information and services specific to your needs <find out more>.
- Search our Help and Support directory to find your preferred support, by adding your location or postcode and filtering by service type.
- The Stimulant Treatment Line offers free counselling and support for people who use stimulants, such as methamphetamine (ice), cocaine and ecstasy: 1800 101 188.
Path2Help
Not sure what you are looking for? Try our intuitive Path2Help tool and be matched with support information and services tailored to you.
Find out more
Use of MDA is against the law. Australian federal and state laws provide penalties for possessing, using, making, selling, importing, exporting, or driving under the influence of MDA.52
- European Monitoring Centre for Drugs and Drug Addiction. Drug profiles: glossary Empathogens [Internet]. Cited 2025 Sep 9.
- Oeri HE. Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy. Journal of psychopharmacology (Oxford, England) [Internet]. 2021;35(5):512–536. Cited 2025 Oct 10.
- Saez-Briones P, Hernandez A. MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology. Current Neuropharmacology [Internet]. 2013;11(5):521–534. Cited 2025 Oct 10.
- Parker MA, Marona-Lewicka D, Kurrasch D, Shulgin AT, Nichols DE. Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA). Journal of Medicinal Chemistry [Internet]. 1998;41(6):1001–1005. Cited 2025 Oct 10.
- Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA. Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors. Neuroscience Letters [Internet]. 1994;177(1-2):111–115. Cited 2025 Oct 10.
- Substance. Drug Infosheets: MDMA / MDA [Internet]. Substance; 2025. Cited 2025 Oct 10.
- Simmler LD, Liechti ME. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances. In: Maurer H, Brandt S, editors. New Psychoactive Substances : Pharmacology, Clinical, Forensic and Analytical Toxicology [Internet]. 2018. p. 143. Cited 2025 Oct 14.
- Lövheim H. A new three-dimensional model for emotions and monoamine neurotransmitters. Medical Hypotheses [Internet]. 2012;78(2):341–348. Cited 2025 Oct 13.
- Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, et al. Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers. Journal of Psychoactive Drugs [Internet]. 2019;51(2):108–117. Cited 2025 Oct 10.
- Australian Government Department of Health and Aged Care. Types of drugs. [Internet]. 2021. Updated 2021 Jun 21. Cited 2025 Nov 11.
- Nichols DE. Psychedelics. Pharmacological Reviews [Internet]. 2016;68(2):264–355. Cited 2025 Nov 11.
- Release. MDA [Internet]. Release; 2024. Cited 2025 Oct 13.
- Sutherland R, Karlsson A, Uporova J, Palmer L, Tayeb H, Chrzanowska A, et al. Australian Drug Trends 2025: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews [Internet]. Syndey, NSW: National Drug and Alcohol Research Centre; 2025. Cited 2025 Oct 14.
- Positive Choices. What are “Party Drugs”/MDMA/Ecstasy? [Internet]. 2025. Updated 2025 Apr 14. Cited 2025 Oct 14.
- Psychonaut Wiki. MDA [Internet]. 2024. Cited 2025 Oct 10.
- Pederson T. The Similarities and Differences of MDA vs. MDMA [Internet]. healthline; 2024. Updated 2024 Oct 29. Cited 2025 Oct 13.
- Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [Internet]. 2001;165(7):917–928. Cited 2025 Oct 14.
- Australian Criminal Intelligence Commission. National Wastewater Drug Monitoring Program - Report 24 [Internet]. Canberra, ACT: Commonwealth of Australia; 2025. Cited 2025 Nov 11.
- Camilleri AM, Caldicott D. Underground pill testing, down under. Forensic Science International [Internet]. 2005;151(1):53–58. Cited 2025 Oct 10.
- CanTEST Health and Drug Checking Serivice. Test Results. Month 36 [Internet]. Canberra, ACT: CanTEST; 2025. Cited 2025 Oct 10.
- CanTEST Health and Drug Checking Serivice. Test Results. Month 33 [Internet]. Canberra, ACT: CanTEST; 2025. Cited 2025 Oct 10.
- Victorian Pill Testing Service. Service Report: The Warehouse Project Single day event 25 April 2025 [Internet]. Melbourne, Vic: 2025. Cited 2025 Oct 10.
- Harm Reduction Victoria. MDMA [Internet]. Cited 2025 Oct 13.
- Sternberg BS, Cataldo LJ, Willingham EJ. Ecstasy. In: Narins B, editor. The Gale Encyclopedia of Mental Health [Internet]. 5th ed. Vol. 2. Farmington Hills, MI: Gale; 2024. Cited 2025 Oct 14.
- Olsen A, Baillie G, Bruno R, McDonald D, Hammoud M, Peacock A. CanTEST Health and Drug Checking Service Program Evaluation: Final Report [Internet]. Canberra, ACT: CanTEST; 2023. Cited 2025 Sep 11.
- Psychonaut Wiki. Duration [Internet]. 2024. Updated 2024 Jun 02. Cited 2025 Oct 13.
- Baggott MJ, Siegrist JD, Galloway GP, Robertson LC, Coyle JR, Mendelson JE, et al. Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans. PloS One [Internet]. 2010;5(12). Cited 2025 Oct 10.
- Nutt D. Drugs without the hot air : making sense of legal and illegal drugs [Internet]. 2nd ed. Cambridge: UIT Cambridge Ltd; 2020. Cited 2025 Oct 02.
- Gashi L, Sandberg S, Pedersen W. Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences. International Journal on Drug Policy [Internet]. 2021;87:102997. Cited 26.09.2024.
- Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB. Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics. Journal of Affective Disorders [Internet]. 2023;326:105–110. Cited 2025 Oct 07.
- Studerus E, Gamma A, Kometer M, Vollenweider FX, Mazza M. Prediction of Psilocybin Response in Healthy Volunteers. PloS One [Internet]. 2012;7(2). Cited 06/08/2024.
- Palmer M, Maynard OM. Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience. Harm Reduct J [Internet]. 2022;19(1):81. Cited 2025 Nov 11.
- Schifano F. A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology [Internet]. 2004;173(3-4):242–248. Cited 2025 Oct 13.
- Schifano F, Oyefeso A, Webb L, Pollard M, Corkery J, Ghodse AH. Review of deaths related to taking ecstasy, England and Wales, 1997-2000. BMJ [Internet]. 2003;326(7380):80. Cited 2025 Oct 13.
- Heart Foundation. Heart attack warning signs [Internet]. 2024. Cited 2025 Nov 11.
- Upfal J. Australian drug guide: the plain language guide to the top 300 drugs and medicines, plus more. Ninth edition ed. Collingwood, Vic: Black Inc.; 2022.
- Darke S, Lappin, J. & Farrell, M. The Clinician's Guide to Illicit Drugs. United Kingdom: Silverback Publishing; 2019.
- Schuckit MA. Drug and alcohol abuse : a clinical guide to diagnosis and treatment [Internet]. 6th ed. Springer; 2006. Cited 2025 Feb 13.
- Scotton WJ, Hill LJ, Williams AC, Barnes NM. Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. Int J Tryptophan Res [Internet]. 2019;12:1178646919873925. Cited 11/10/2024.
- Giulini F, Keenan E, Killeen N, Ivers J-H. A Systematized Review of Drug-checking and Related Considerations for Implementation as A Harm Reduction Intervention. Journal of Psychoactive Drugs [Internet]. 2023;55(1):85–93. Cited 2025 Nov 11.
- Drug Science. MDMA (Ecstasy). [Internet]. 2022. Cited 2025 Nov 11.
- Hi-Ground. MDMA [Internet]. n.d. Cited 2025 Nov 11.
- Change Grow Live. What is chemsex? Support, advice and how to stay safe. [Internet]. 2025. Cited 2025 Nov 11.
- headspace. understanding sexual consent [Internet]. 2023. Updated 2023 Feb 13. Cited 2025 Oct 14.
- Psychonaut Wiki. Brain zaps [Internet]. 2022. Updated 2022 Jun 04. Cited 2025 Oct 14.
- Boys A, Marsden J, Strang J. Understanding reasons for drug use amongst young people: a functional perspective. Health Education Research [Internet]. 2001;16(4):457–469. Cited 2025 Oct 10.
- Halladay J, Woock R, El-Khechen H, Munn C, MacKillop J, Amlung M, et al. Patterns of substance use among adolescents: A systematic review. Drug and Alcohol Dependence [Internet]. 2020;216:108222. Cited 2025 Oct 20.
- Korsmeyer P, Kranzler HR. Lysergic Acid Diethylamide (LSD) and Psychedelics. Encyclopedia of Drugs, Alcohol & Addictive Behavior, [Internet]. 2009;2:372–378. Cited 2025 Nov 11.
- Nayak SM, Johnson MW. Disorders due to Substance Use: Hallucinogens and MDMA-Related Substances. In: Tasman A, et al, editors. Tasman’s Psychiatry [Internet]. Springer, Cham; 2023. p. 1–34. Cited 2025 Oct 14.
- Talk to Frank. Ecstasy [Internet]. n.d. Cited 2025 Oct 14.
- Health NMo. Management of Withdrawal from Alcohol and Other Drugs Clinical Guidance [Internet]. St Leonards, NSW: 2022. Cited 2025 Oct 07.
- Australian Government. Criminal Code Regulations 2019. Canberra, ACT: 2019.